Israeli Group to Study MDMA Therapy for October 7 Survivors With PTSD

Israeli Group to Study MDMA Therapy for October 7 Survivors With PTSD

A group of 400 Israeli survivors of the October 7 Hamas attack, including civilians, released hostages, and soldiers, could be offered MDMA-assisted psychotherapy in a potentially trailblazing study to commence later this year.

“Our goal is to create a therapy model that can serve universally, with the intention and prayer to help people,” said Dr. Keren Tzarfaty, CEO and co-founder of MAPS Israel, which is already running trials evaluating MDMA-assisted therapy for the treatment of post-traumatic stress disorder, depression, and eating disorders. “We hope it will demonstrate high levels of safety and effectiveness and enable us to offer the program in other places over the region and the world, not only to treat PTSD, but to help people open their hearts and expand their minds.”

Dr. Rick Doblin, founding president of the U.S.-based MAPS and a longtime advocate for using psychedelic therapy in the Israeli–Palestinian conflict, said that the study would serve as a seminal piece of research into whether psychedelic-assisted therapy can help large groups of traumatized people.

Read More »

Cyber Forces Manipulate Public Opinion

Cyber Forces Manipulate Public Opinion

Wuhan University working with NATO?! 😳

Source:

The project is supported by the following five partner institutions: the Czech National Cyber and Information Security Agency (NCISA), the International Committee of the Red Cross (ICRC), the NATO Cooperative Cyber Defence Centre of Excellence (CCD COE), the University of Exeter, United Kingdom, and Wuhan University, China. The core of the project team consists of Dr Kubo Mačák (ICRC) – General Editor; Mr Tomáš Minárik (NCISA) – Managing Editor; and Ms Taťána Jančárková (CCD COE) – Scenario Editor. The pilot year of the project (2018/19) was supported through the UK ESRC IAA Project Co-Creation scheme. The individual scenarios and the Toolkit as such have been reviewed by a team of over 20 peer reviewers. The Toolkit was formally launched on 28 May 2019 in Tallinn, Estonia; its Chinese launch took place on 2 November 2019 in Wuhan, China; and it remains continuously updated.